AVEFX
Price
$12.36
Change
+$0.05 (+0.41%)
Updated
Dec 3 closing price
Net Assets
796.62M
RBBCX
Price
$12.41
Change
+$0.04 (+0.32%)
Updated
Dec 3 closing price
Net Assets
849.6M
Interact to see
Advertisement

AVEFX vs RBBCX

Header iconAVEFX vs RBBCX Comparison
Open Charts AVEFX vs RBBCXBanner chart's image
Ave Maria Bond
Price$12.36
Change+$0.05 (+0.41%)
VolumeN/A
Net Assets796.62M
Columbia Income Builder C
Price$12.41
Change+$0.04 (+0.32%)
VolumeN/A
Net Assets849.6M
AVEFX vs RBBCX Comparison Chart in %
View a ticker or compare two or three
VS
AVEFX vs. RBBCX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVEFX is a Hold and RBBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RBBCX has more cash in the bank: 850M vs. AVEFX (797M). AVEFX pays higher dividends than RBBCX: AVEFX (3.32) vs RBBCX (3.07). AVEFX was incepted earlier than RBBCX: AVEFX (23 years) vs RBBCX (20 years). RBBCX (1.72) is less costly to investors than AVEFX (0.42). AVEFX is a more actively managed with annual turnover of: 20.00 vs. RBBCX (18.00). RBBCX has a lower initial minimum investment than AVEFX: RBBCX (2000) vs AVEFX (2500). RBBCX annual gain was more profitable for investors over the last year : 6.58 vs. AVEFX (2.75). AVEFX return over 5 years is better than : 16.01 vs. RBBCX (9.34).
AVEFXRBBCXAVEFX / RBBCX
Total Expense Ratio0.421.7224%
Annual Report Gross Expense Ratio0.421.7224%
Fund Existence23 years20 years-
Gain YTD5.0099.32954%
Front LoadN/AN/A-
Min. Initial Investment25002000125%
Min. Initial Investment IRAN/A1000-
Net Assets797M850M94%
Annual Yield % from dividends3.323.07108%
Returns for 1 year2.756.5842%
Returns for 3 years13.8420.4368%
Returns for 5 years16.019.34171%
Returns for 10 years35.4342.1984%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CATO3.470.05
+1.46%
CATO Corp
STRD78.681.09
+1.41%
MicroStrategy Inc
WLYB36.320.01
+0.03%
John Wiley & Sons
BMRN53.89-1.14
-2.07%
BioMarin Pharmaceutical
NMRA2.23-0.18
-7.64%
Neumora Therapeutics